Lv58
1420 积分 2022-11-14 加入
Risk-based Strategy to Determine Testing Requirement for the Removal of Residual Process Reagents as Process-related Impurities in Bioprocesses
2小时前
已完结
An Update on Patent issues regarding Antibody Drug Conjugates
6天前
已完结
The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity
13天前
已完结
Cascade-Type Microglial Pyroptosis Inhibitors for Enhanced Treatment of Cerebral Ischemia-Reperfusion Injury
16天前
已完结
The Next Generation of Antibody Drug Conjugates
1个月前
已完结
Discovery of a potent dual-target CDK8 and cyclin C PROTAC degrader for the treatment of colorectal cancer
1个月前
已完结
A patent review of mutant-selective PI3Kα inhibitors for the treatment of different cancers (2021–2025)
1个月前
已完结
Generation of DAR1 Glycosite‐Specific Antibody‐Drug Conjugates Using DisacLink Technology
1个月前
已完结
Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study
2个月前
已关闭
Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase Ii study
2个月前
已关闭
皖公网安备34019202002308
